Endocan: a biomarker predicting successful reperfusion after coronary artery by-pass surgery of acute coronary syndrome patients.
European review for medical and pharmacological sciences, vol.23, no.1, pp.338-342, 2019 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 23 Issue: 1
- Publication Date: 2019
- Doi Number: 10.26355/eurrev_201901_16781
- Journal Name: European review for medical and pharmacological sciences
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.338-342
- Istanbul University Affiliated: Yes
Abstract
OBJECTIVE: Endothelial specific molecule 1 (Endocan) is a biomarker of the inflammatory process occurring in endothelial cells. It was shown that endocan was increased in acute coronary syndromes. We aimed at investigating the endocan levels in acute coronary syndrome patients after coronary bypass surgery.